Access & Prescribing (Australia & Global)
Hawaii Report: Medical Cannabis Patient Status Leading Cause of Gun Permit Denials
Hawaii's report reveals medical cannabis patient status is the top reason for gun permit denials. Explore the impact on medical cannabis gun rights and fe…
Access & Prescribing (Australia & Global)
ASX Medicinal Cannabis Market Activity Highlighted by LGP, CAN, and AGH Performance
Explore recent movements in the ASX medicinal cannabis market, focusing on companies like LGP, CAN, and AGH. Understand how healthcare adoption and policy…
Access & Prescribing (Australia & Global)
Speakeasy Dispensary Opens New Medical Cannabis Location in Bowling Green, Kentucky
Speakeasy Dispensary has opened a new medical cannabis location in Bowling Green, Kentucky, expanding patient access. Learn about the services, product av…
Clinical Trials & Medical Research
Research Explores Muskmelon By-Products for Natural Antimicrobial Potential
New research suggests muskmelon by-products, often discarded, contain bioactive compounds with natural antimicrobial potential. This study explores their…
Cannabinoid Pharmacology
Review Highlights Atractylenolide III’s Neuroprotective Potential for Central Nervous System Disorders
A 2026 review in Frontiers in Pharmacology explores Atractylenolide III's neuroprotective mechanisms and therapeutic potential for central nervous system…
Australian Cannabis Policy & Law
Nebraska, Indiana, and Louisiana Attorneys General Sue to Block Federal Medical Cannabis Reclassification
Nebraska, Indiana, and Louisiana Attorneys General have filed a lawsuit to halt the federal medical cannabis reclassification from Schedule I to Schedule…
Discover how industrial hemp plants naturally defend against the corn earworm, a pest that can destroy up to 60% of yields. University of Maryland researc…
Access & Prescribing (Australia & Global)
Medical Cannabis Rescheduling Shifts Consumer Sentiment, Faces Consolidated Legal Challenges
A new NuggMD and Marijuana Moment survey reveals significant consumer support for medical cannabis rescheduling, with 73% approving of the administration'…
Cannabinoid Pharmacology
New Research Challenges ‘Lazy Stoner’ Stereotype, Links Cannabis Use to Light and Moderate Physical Activity
Emerging research from the University of Alabama at Birmingham suggests cannabis use is associated with light to moderate physical activity, challenging c…
Access & Prescribing (Australia & Global)
Jushi Holdings Inc. Applies for DEA Registration of State-Licensed Medical Cannabis Operations
Jushi Holdings Inc. has submitted applications for DEA registration of its state-licensed medical cannabis operations, aligning with the new federal Sched…
